Literature DB >> 8833984

Determination of FGN-1 (an active metabolite of sulindac) in human plasma, urine, and feces by HPLC.

G F Ray1, R C Lanman, C J Fu, N S Paranka, R Pamukcu, S C Wheeler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8833984     DOI： 10.1016/0731-7085(95)01631-7

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN： 0731-7085            Impact factor:   3.935


× No keyword cloud information.
  5 in total

1.  Population pharmacokinetic model for cancer chemoprevention with sulindac in healthy subjects.

Authors:  Alexander K Berg; Sumithra J Mandrekar; Katie L Allen Ziegler; Elsa C Carlson; Eva Szabo; Mathew M Ames; Daniel Boring; Paul J Limburg; Joel M Reid
Journal:  J Clin Pharmacol       Date:  2013-02-22       Impact factor: 3.126

Review 2.  Clinical pharmacokinetics of sulindac. A dynamic old drug.

Authors:  N M Davies; M S Watson
Journal:  Clin Pharmacokinet       Date:  1997-06       Impact factor: 6.447

3.  Phase I/II study of vinorelbine and exisulind as first-line treatment of advanced non-small cell lung cancer in patients at least 70 years old: a wisconsin oncology network study.

Authors:  Steven Attia; Anne M Traynor; Kyungmann Kim; Joseph J Merchant; Tien Hoang; Harish G Ahuja; Peter A Beatty; Richard M Hansen; Gregory A Masters; Kurt R Oettel; Gary R Shapiro; Martha M Larson; Marilyn L Larson; Joan H Schiller
Journal:  J Thorac Oncol       Date:  2008-09       Impact factor: 15.609

4.  Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-κB inhibitors in ovarian cancer therapy.

Authors:  Luiz F Zerbini; Rodrigo E Tamura; Ricardo G Correa; Akos Czibere; Jason Cordeiro; Manoj Bhasin; Fernando M Simabuco; Yihong Wang; Xuesong Gu; Linglin Li; Devanand Sarkar; Jin-Rong Zhou; Paul B Fisher; Towia A Libermann
Journal:  PLoS One       Date:  2011-09-12       Impact factor: 3.240

5.  Sulindac sulfide reverses aberrant self-renewal of progenitor cells induced by the AML-associated fusion proteins PML/RARα and PLZF/RARα.

Authors:  Gunnar Steinert; Claudia Oancea; Jessica Roos; Heike Hagemeyer; Thorsten Maier; Martin Ruthardt; Elena Puccetti
Journal:  PLoS One       Date:  2011-07-19       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.